Factor VIII Antikörper (AA 1451-1550)

Produktnummer ABIN728000

Der Kaninchen Polyklonal Anti-Factor VIII Antikörper wurde für ELISA, IF (p), IF (cc), IHC (p) und IHC (fro) validiert. Er ist geeignet, Factor VIII in Proben von Human und Maus zu detektieren. Es sind 4+ Publikationen verfügbar.

Kurzübersicht für Factor VIII Antikörper (AA 1451-1550) (ABIN728000)

Target: Factor VIII (F8) (Coagulation Factor VIII (F8))

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Factor VIII Antikörper ist unkonjugiert

Applikation: ELISA, Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Produktdetails anti-Factor VIII Antikörper

Bindungsspezifität: AA 1451-1550

Kreuzreaktivität: Human, Maus

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human factor VIII

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Referenzen für anti-Factor VIII Antikörper (ABIN728000)

Hu, Zhou, Gao, Liu, Yan, Zou, Chen: "IFN-? inhibits osteopontin expression in human decidual stromal cells and can be attenuated by 1?,25-dihydroxyvitamin D3." in: American journal of reproductive immunology (New York, N.Y. : 1989), Vol. 68, Issue 4, pp. 353-61, (2012) (PubMed).

Hu, Song, He, Freeman, Parish, Yuan, Yu, Tang: "Heparanase and vascular endothelial growth factor expression is increased in hypoxia-induced retinal neovascularization." in: Investigative ophthalmology & visual science, Vol. 53, Issue 11, pp. 6810-7, (2012) (PubMed).

Li, Ye, Guo, Yang: "Suppression of bladder cancer cell tumorigenicity in an athymic mouse model by adenoviral vector-mediated transfer of LRIG1." in: Oncology reports, Vol. 26, Issue 2, pp. 439-46, (2011) (PubMed).

Zhou, Zhu, Zou, Wang: "Changes in number and biological function of endothelial progenitor cells in hypertension disorder complicating pregnancy." in: Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, Vol. 28, Issue 6, pp. 670-3, (2008) (PubMed).

Details zu Factor VIII

Target: Factor VIII (F8) (Coagulation Factor VIII (F8))

Andere Bezeichnung: factor 8/F8

Hintergrund:

Synonyms: AHF, F8B, F8C, HEMA, FVIII, DXS1253E, Coagulation factor VIII, Antihemophilic factor, Procoagulant component, F8

Background: Factor VIII, along with calcium and phospholipid, acts as a cofactor for factor IXa when it converts factor X to the activated form, factor Xa.

Gen-ID: 2157

UniProt: P00451